Help
RSS
API
Feed
Maltego
Contact
Domain > esplifesciences.com
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2016-03-10
46.30.212.241
(
ClassC
)
2025-01-13
46.30.213.186
(
ClassC
)
Port 80
HTTP/1.1 200 OKDate: Sat, 28 Sep 2024 22:31:28 GMTServer: ApacheLast-Modified: Fri, 26 Jun 2015 09:30:22 GMTVary: Accept-EncodingContent-Type: text/htmlX-Onecom-Cluster-Name: X-Varnish: 168075556Age: !DOCTYPE html>html manifestindex.hyperesources/cache.manifest> head> meta http-equivContent-Type contenttext/html; charsetutf-8 /> meta http-equivX-UA-Compatible contentchrome1,IEedge /> title>ESP/title> style> html { height:100%; } body { margin:0; height:100%; } /style> !-- copy these lines to your document head: --> meta nameviewport contentuser-scalableyes, width1000 /> meta nameapple-mobile-web-app-capable contentyes /> !-- end copy --> /head> body> !-- copy these lines to your document: --> div idindex_hype_container stylemargin:auto;position:relative;width:1000px;height:1200px;overflow:hidden; aria-livepolite> script typetext/javascript charsetutf-8 srcindex.hyperesources/index_hype_generated_script.js?92516>/script> /div> !-- end copy --> !-- text content for search engines: --> div styledisplay:none> div>Sciences/div> div>/div> div>Services/div> div>Contact/div> div>About ESP/div> div>ESP Life Sciences Consulting AB was founded in February 2014 by the owner Stefan Pierrou. The company has its focus on pharmaceutical project and line management consultancy within the field of Life Sciences. The founder has more than 17 years experience as a line manager and drug project leader within the global pharmaceutical industry and is currently the base of the company’s asset./div> div>Stefan Pierrou is an experienced drug project leader and line manager from the pharmaceutical industry. He received his basic training at Chalmers University and graduated as MSc in chemical engineering in 1991. Five years later he defended his thesis “Human forkhead genes” in the field of transcription factors and their control at Medicinareberget in Gothenburg. He then moved to Lund and Astra and soon took on group leading roles in the Cell and Molecular Biology department. After various positions leading different research groups within the bioinformatics, genomics and proteomics field he moved to Mölndal and AstraZeneca in 2002 where he had several drug project and line leading responsibilites wit
Port 443
HTTP/1.1 200 OKDate: Sat, 28 Sep 2024 22:31:29 GMTServer: ApacheLast-Modified: Fri, 26 Jun 2015 09:30:22 GMTVary: Accept-EncodingContent-Type: text/htmlX-Onecom-Cluster-Name: X-Varnish: 141371496Age: !DOCTYPE html>html manifestindex.hyperesources/cache.manifest> head> meta http-equivContent-Type contenttext/html; charsetutf-8 /> meta http-equivX-UA-Compatible contentchrome1,IEedge /> title>ESP/title> style> html { height:100%; } body { margin:0; height:100%; } /style> !-- copy these lines to your document head: --> meta nameviewport contentuser-scalableyes, width1000 /> meta nameapple-mobile-web-app-capable contentyes /> !-- end copy --> /head> body> !-- copy these lines to your document: --> div idindex_hype_container stylemargin:auto;position:relative;width:1000px;height:1200px;overflow:hidden; aria-livepolite> script typetext/javascript charsetutf-8 srcindex.hyperesources/index_hype_generated_script.js?92516>/script> /div> !-- end copy --> !-- text content for search engines: --> div styledisplay:none> div>Sciences/div> div>/div> div>Services/div> div>Contact/div> div>About ESP/div> div>ESP Life Sciences Consulting AB was founded in February 2014 by the owner Stefan Pierrou. The company has its focus on pharmaceutical project and line management consultancy within the field of Life Sciences. The founder has more than 17 years experience as a line manager and drug project leader within the global pharmaceutical industry and is currently the base of the company’s asset./div> div>Stefan Pierrou is an experienced drug project leader and line manager from the pharmaceutical industry. He received his basic training at Chalmers University and graduated as MSc in chemical engineering in 1991. Five years later he defended his thesis “Human forkhead genes” in the field of transcription factors and their control at Medicinareberget in Gothenburg. He then moved to Lund and Astra and soon took on group leading roles in the Cell and Molecular Biology department. After various positions leading different research groups within the bioinformatics, genomics and proteomics field he moved to Mölndal and AstraZeneca in 2002 where he had several drug project and line leading responsibilites wit
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]